Status:
UNKNOWN
Qualitative Exploratory Study Among Reunionese Women and Their Partners Who Have a Child With Trisomy 21
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Down Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
According to data from French congenital malformation registries, the prevalence of Down Syndrome (DS) in 2017 (live births and medical termination of pregnancy (MToP)) in Reunion Island was the lowes...
Eligibility Criteria
Inclusion
- Parents:
- of a child born alive with Down Syndrome as of January 1, 2019 and registered within REMACOR
- living on the island of Reunion at the time of birth
- having a good understanding of French and/or Creole
- having given their written consent to the study
Exclusion
- Parents:
- with normal/negative prenatal screening (False positive)
- minors at the time of inclusion
- under guardianship or legal protection
- with a pathology preventing the interviews from taking place
Key Trial Info
Start Date :
February 28 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04811534
Start Date
February 28 2022
End Date
June 1 2025
Last Update
April 1 2022
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Réunion
Saint-Denis, Reunion, 97400
2
CHU de la Réunion
Saint-Pierre, Reunion, 97448